OPEN END TURBO LONG - BAUSCH HEALTH Share Price

Certificat

DE000MD7L9A4

Market Closed - Bid/Ask 11:39:33 23/05/2024 pm IST After market 01:18:37 am
0.97 EUR -10.19% Intraday chart for OPEN END TURBO LONG - BAUSCH HEALTH 1.025 +5.67%
Current month-68.33%
1 month-64.59%
Date Price Change
23/24/23 0.97 -10.19%
22/24/22 1.08 -2.70%
21/24/21 1.11 -9.02%
20/24/20 1.22 -15.28%
17/24/17 1.44 -16.28%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 11:39 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BAUSCH HEALTH COMPANIES INC.
Issuer Morgan Stanley
WKN MD7L9A
ISINDE000MD7L9A4
Date issued 30/08/2022
Strike 5.291 $
Maturity Unlimited
Parity 1 : 1
Emission price 0.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.19
Lowest since issue 0.97
Spread 0.03
Spread %2.88%

Company Profile

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Sector
-
More about the company

Ratings for Bausch Health Companies Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Bausch Health Companies Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
6.37 USD
Average target price
9.786 USD
Spread / Average Target
+53.62%
Consensus